A validated composite comorbidity index predicts outcomes of CAR T-cell therapy in patients with diffuse large B-cell lymphoma.
Saved in:
| Title: | A validated composite comorbidity index predicts outcomes of CAR T-cell therapy in patients with diffuse large B-cell lymphoma. |
|---|---|
| Authors: | Shouse G; Division of Lymphoma, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA., Kaempf A; Biostatistics Shared Resource, Knight Cancer Institute, Oregon Health & Science University, Portland, OR., Gordon MJ; Department of Lymphoma, MD Anderson Cancer Center, Houston, TX., Artz A; Division of Lymphoma, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA., Yashar D; Division of Lymphoma, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA., Sigmund AM; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH., Smilnak G; Division of Hematology/Oncology, Northwestern University, Chicago, IL., Bair SM; University of Colorado Cancer Center, University of Colorado, Aurora, CO., Mian A; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH., Fitzgerald LA; Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT., Bajwa A; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH., Jaglowski S; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH., Bailey N; Center for Blood Disorders and Cellular Therapy, Swedish Cancer Institute, Seattle, WA., Shadman M; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA., Patel K; Center for Blood Disorders and Cellular Therapy, Swedish Cancer Institute, Seattle, WA., Stephens DM; Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT., Kamdar M; University of Colorado Cancer Center, University of Colorado, Aurora, CO., Hill BT; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH., Gauthier J; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA., Karmali R; Division of Hematology/Oncology, Northwestern University, Chicago, IL., Nastoupil LJ; Department of Lymphoma, MD Anderson Cancer Center, Houston, TX., Kittai AS; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH., Danilov AV; Division of Lymphoma, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA. |
| Source: | Blood advances [Blood Adv] 2023 Jul 25; Vol. 7 (14), pp. 3516-3529. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 36735393 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: A validated composite comorbidity index predicts outcomes of CAR T-cell therapy in patients with diffuse large B-cell lymphoma. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Shouse+G%22">Shouse G</searchLink>; Division of Lymphoma, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA.<br /><searchLink fieldCode="AU" term="%22Kaempf+A%22">Kaempf A</searchLink>; Biostatistics Shared Resource, Knight Cancer Institute, Oregon Health & Science University, Portland, OR.<br /><searchLink fieldCode="AU" term="%22Gordon+MJ%22">Gordon MJ</searchLink>; Department of Lymphoma, MD Anderson Cancer Center, Houston, TX.<br /><searchLink fieldCode="AU" term="%22Artz+A%22">Artz A</searchLink>; Division of Lymphoma, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA.<br /><searchLink fieldCode="AU" term="%22Yashar+D%22">Yashar D</searchLink>; Division of Lymphoma, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA.<br /><searchLink fieldCode="AU" term="%22Sigmund+AM%22">Sigmund AM</searchLink>; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH.<br /><searchLink fieldCode="AU" term="%22Smilnak+G%22">Smilnak G</searchLink>; Division of Hematology/Oncology, Northwestern University, Chicago, IL.<br /><searchLink fieldCode="AU" term="%22Bair+SM%22">Bair SM</searchLink>; University of Colorado Cancer Center, University of Colorado, Aurora, CO.<br /><searchLink fieldCode="AU" term="%22Mian+A%22">Mian A</searchLink>; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH.<br /><searchLink fieldCode="AU" term="%22Fitzgerald+LA%22">Fitzgerald LA</searchLink>; Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT.<br /><searchLink fieldCode="AU" term="%22Bajwa+A%22">Bajwa A</searchLink>; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH.<br /><searchLink fieldCode="AU" term="%22Jaglowski+S%22">Jaglowski S</searchLink>; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH.<br /><searchLink fieldCode="AU" term="%22Bailey+N%22">Bailey N</searchLink>; Center for Blood Disorders and Cellular Therapy, Swedish Cancer Institute, Seattle, WA.<br /><searchLink fieldCode="AU" term="%22Shadman+M%22">Shadman M</searchLink>; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA.<br /><searchLink fieldCode="AU" term="%22Patel+K%22">Patel K</searchLink>; Center for Blood Disorders and Cellular Therapy, Swedish Cancer Institute, Seattle, WA.<br /><searchLink fieldCode="AU" term="%22Stephens+DM%22">Stephens DM</searchLink>; Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT.<br /><searchLink fieldCode="AU" term="%22Kamdar+M%22">Kamdar M</searchLink>; University of Colorado Cancer Center, University of Colorado, Aurora, CO.<br /><searchLink fieldCode="AU" term="%22Hill+BT%22">Hill BT</searchLink>; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH.<br /><searchLink fieldCode="AU" term="%22Gauthier+J%22">Gauthier J</searchLink>; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA.<br /><searchLink fieldCode="AU" term="%22Karmali+R%22">Karmali R</searchLink>; Division of Hematology/Oncology, Northwestern University, Chicago, IL.<br /><searchLink fieldCode="AU" term="%22Nastoupil+LJ%22">Nastoupil LJ</searchLink>; Department of Lymphoma, MD Anderson Cancer Center, Houston, TX.<br /><searchLink fieldCode="AU" term="%22Kittai+AS%22">Kittai AS</searchLink>; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH.<br /><searchLink fieldCode="AU" term="%22Danilov+AV%22">Danilov AV</searchLink>; Division of Lymphoma, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101698425%22">Blood advances</searchLink> [Blood Adv] 2023 Jul 25; Vol. 7 (14), pp. 3516-3529. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+of+Hematology%22">American Society of Hematology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101698425 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2473-9537 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2224739529%22">24739529 </searchLink><i>NLM ISO Abbreviation: </i>Blood Adv <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36735393 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1182/bloodadvances.2022009309 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 3516 Titles: – TitleFull: A validated composite comorbidity index predicts outcomes of CAR T-cell therapy in patients with diffuse large B-cell lymphoma. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Shouse G – PersonEntity: Name: NameFull: Kaempf A – PersonEntity: Name: NameFull: Gordon MJ – PersonEntity: Name: NameFull: Artz A – PersonEntity: Name: NameFull: Yashar D – PersonEntity: Name: NameFull: Sigmund AM – PersonEntity: Name: NameFull: Smilnak G – PersonEntity: Name: NameFull: Bair SM – PersonEntity: Name: NameFull: Mian A – PersonEntity: Name: NameFull: Fitzgerald LA – PersonEntity: Name: NameFull: Bajwa A – PersonEntity: Name: NameFull: Jaglowski S – PersonEntity: Name: NameFull: Bailey N – PersonEntity: Name: NameFull: Shadman M – PersonEntity: Name: NameFull: Patel K – PersonEntity: Name: NameFull: Stephens DM – PersonEntity: Name: NameFull: Kamdar M – PersonEntity: Name: NameFull: Hill BT – PersonEntity: Name: NameFull: Gauthier J – PersonEntity: Name: NameFull: Karmali R – PersonEntity: Name: NameFull: Nastoupil LJ – PersonEntity: Name: NameFull: Kittai AS – PersonEntity: Name: NameFull: Danilov AV IsPartOfRelationships: – BibEntity: Dates: – D: 25 M: 07 Text: 2023 Jul 25 Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 2473-9537 Numbering: – Type: volume Value: 7 – Type: issue Value: 14 Titles: – TitleFull: Blood advances Type: main |
| ResultId | 1 |